TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:TEVA

<< 前へ 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2019/09/05	11 : 05	Business Wire	Teva präsentiert neue Analysen zur Wirksamkeit und Sicherheit von Fremanezumab bei erwachsenen Patienten mit schwer behandel...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/09/05	06 : 18	Business Wire	Teva présentera de nouvelles analyses sur l'efficacité et l'innocuité du fremanezumab chez les patients adultes atteints d...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/09/05	05 : 14	Business Wire	Teva to Present New Analyses of Fremanezumab Efficacy & Safety in Adult Patients with Difficult-to-Treat Migraine at 19th Con...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/09/04	05 : 05	Business Wire	Teva Announces United States Department of Commerce Appointment of Brendan O’Grady to Investment Advisory Council	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/09/03	22 : 00	Business Wire	Teva to Present New Analyses of Fremanezumab Efficacy & Safety in Adult Patients with Difficult-to-Treat Migraine at 19th Con...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/08/28	05 : 14	Dow Jones News	Shares of Mallinckrodt, Endo, Teva, Drugmakers With Opioid Business, Fall	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/08/21	21 : 00	Business Wire	Fremanezumab Data in The Lancet Demonstrate Clinically Meaningful Reduction in Monthly Migraine Days Versus Placebo for Patie...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/08/20	21 : 00	Business Wire	Teva Announces Availability of a Generic Equivalent of EpiPen Jr® (epinephrine injection, USP) Auto-Injector, 0.15 mg in the...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/08/08	04 : 00	Dow Jones News	Teva Seeks New CFO As It Faces High Debt Levels, Opioid Litigation -- Update	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/08/07	20 : 05	Business Wire	Teva Announces CFO Leadership Transition	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/08/07	20 : 00	Business Wire	Teva Reports Second Quarter 2019 Financial Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/07/23	00 : 36	Dow Jones News	FDA Approves Multiple Applications for Generic Version of Lyrica	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/07/18	06 : 15	Dow Jones News	Medical Distributors Stocks Fall After Opioid Data Reports	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/07/18	03 : 56	Dow Jones News	Medical Distributors Stocks Fall After Opioid Data Reports	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/07/15	22 : 33	Dow Jones News	Teva Pharmaceutical Says FDA Approves AirDuo Digihaler Inhalation Powder	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/07/15	21 : 30	Business Wire	Teva Announces FDA Approval of AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/07/11	21 : 07	Business Wire	Teva Completes Facilities Purchase in Pennsylvania for North America Research & Development Campus	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/07/10	22 : 17	Business Wire	Teva to Present New Data on AJOVY® (fremanezumab-vfrm) Injection at the American Headache Society’s 61st Annual Scientific...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/07/04	06 : 00	Business Wire	Teva to Host Conference Call to Discuss Second Quarter 2019 Financial Results at 8 a.m. ET on August 7, 2019	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/07/02	15 : 30	Business Wire	Teva Presents Positive Results Showing Improvement in Disability & Quality of Life from the Phase IIIb FOCUS study of Fremane...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/07/01	21 : 30	Business Wire	Teva Announces Launch of 1% Sodium Hyaluronate in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/06/20	02 : 00	Business Wire	Teva Announces Launch of a Generic Version of Tracleer® (bosentan) Tablets in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/06/03	16 : 27	Dow Jones News	Shield Therapeutics Faces Appeal from Teva over Ferracru Patent	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/05/30	03 : 30	Dow Jones News	Johnson & Johnson Weighs on Pharmaceutical ETFs	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/05/29	15 : 00	Business Wire	Teva to present new fremanezumab FOCUS Clinical Study Data for the first time at the 13th European Headache Federation Congress	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/05/29	01 : 45	Business Wire	Teva Announces Launch of a Generic Version of Ranexa® (ranolazine) Extended-Release Tablets in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/05/29	01 : 23	Dow Jones News	Opioid Suits May Reduce Appetite for Pharma Companies -- ESG Insight	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/05/27	21 : 29	Dow Jones News	First Big Trial in Opioid Crisis Set to Kick Off in Oklahoma	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/05/27	01 : 50	Dow Jones News	Teva Settles Oklahoma Opioid Case for $85 Million -- Update	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2019/05/27	01 : 39	Dow Jones News	Teva Settles Oklahoma Opioid Case for $85 Million	NYSE:TEVA	Teva Pharmaceutical Industries Ltd